Bridgeway Capital Management’s Vigil Neuroscience VIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-79,864
| Closed | -$142K | – | 1272 |
|
|
2025
Q1 | $142K | Sell |
79,864
-20,200
| -20% | -$36K | ﹤0.01% | 987 |
|
|
2024
Q4 | $170K | Sell |
100,064
-5,000
| -5% | -$8.5K | ﹤0.01% | 1036 |
|
|
2024
Q3 | $357K | Buy |
105,064
+25,000
| +31% | +$85K | 0.01% | 941 |
|
|
2024
Q2 | $320K | Buy |
80,064
+22,100
| +38% | +$88.4K | 0.01% | 961 |
|
|
2024
Q1 | $198K | Sell |
57,964
-75,000
| -56% | -$256K | ﹤0.01% | 1112 |
|
|
2023
Q4 | $449K | Buy |
+132,964
| New | +$449K | 0.01% | 967 |
|